Acute Toxity and Protective Effects of Extracts from Caulis of Schisandra chinensis on Liver Injury in Mice

HU Yan-wu; YU Jun-lin

doi:10.13422/j.cnki.syfjx.2011.15.061

您当前的位置：

首页 >

文章列表页 >

Acute Toxity and Protective Effects of Extracts from Caulis of Schisandra chinensis on Liver Injury in Mice

更新时间：2024-09-23

- Acute Toxity and Protective Effects of Extracts from Caulis of Schisandra chinensis on Liver Injury in Mice
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 17, Issue 15, Pages: 172-174(2011)
- 作者机构：
  
  通化师范学院制药与食品科学系
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2011.15.061
  CLC： R285.5
- Published：2011
- 稿件说明：
移动端阅览
[1]胡彦武,于俊林.五味子藤茎提取物急性毒性试验及对小鼠试验性肝损伤的保护作用[J].中国实验方剂学杂志,2011,17(15):172-174.

HU Yan-wu, YU Jun-lin. Acute Toxity and Protective Effects of Extracts from Caulis of Schisandra chinensis on Liver Injury in Mice[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(15): 172-174.
[1]胡彦武,于俊林.五味子藤茎提取物急性毒性试验及对小鼠试验性肝损伤的保护作用[J].中国实验方剂学杂志,2011,17(15):172-174. DOI： 10.13422/j.cnki.syfjx.2011.15.061.

HU Yan-wu, YU Jun-lin. Acute Toxity and Protective Effects of Extracts from Caulis of Schisandra chinensis on Liver Injury in Mice[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(15): 172-174. DOI： 10.13422/j.cnki.syfjx.2011.15.061.

摘要

目的:观察五味子藤茎提取物的对小鼠急性毒性反应及其对CCl4致小鼠肝损伤动物模型的保护作用。方法:测定最大给药浓度（0.40 g.mL-1）

最大体积（0.04 mL.g-1）的2次ig对小鼠最大耐受量（MTD）

并采用CCl4致小鼠急性肝损伤模型

观察五味子藤茎提取物低、中、高剂量（3.03

4.55

9.09 g.kg-1）对肝损伤小鼠血清丙氨酸转氨酶（ALT）

天冬氨酸转氨酶（AST）水平的影响。结果:五味子藤茎提取物对小鼠1次ig MTD为32 g.kg-1.d-1

五味子藤茎提取物各剂量组均能降低小鼠血清ALT

AST水平

与模型组比较

高、中剂量组差异显著（P<0.05

P<0.01）。结论:五味子藤茎提取物毒性较低

对CCl4致小鼠急性肝损伤具有较强的保护作用。

Abstract

Objective:To evaluate the acute toxicity and the protective effects of the extraction from caulis of Schisandra chinensis on acute hepatic injury induced by carbon tetrachloride（CCl4） in mice.Method:The maximum dosage（concentration 0.40 g·mL-1

dose 0.04 mL·g-1） of the extraction from caulis of S.chinensis was used as ig administration in mice to measure the maximum tolerance dose（MTD）.With different doses of the extracts（ig 3.03

4.55

9.09 g·kg-1）

the levels of ALT and AST in serum were observed for acute liver injury induced by CCl4 in mice.Result:The MTD of the extraction in mice was 32 g·kg-1·d-1.All dose groups of the extraction from caulis of S.chinensis could decrease the levels of ALT and AST in serum.Compared with the model control group

moderate and high dose groups could significantly decrease the levels of ALT and AST in serum（P<0.05

P<0.01）.Conclusion:The extraction from caulis of S.chinensin has low toxicity

and shows protective effect on acute liver injury induced by CCl4 in mice.

关键词

Keywords

references

Views

353

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research Advances on Anti-inflammatory and Anti-oxidation Effect of Medicinal and Edible Herbs Liver-protecting Chinese Medicine

Compound Glycyrrhizin Tablets Ameliorate Liver Injury Induced by Tripterygium Glycosides Tablet by Regulating Cholesterol Metabolism

Effect of Modified Dahuang Huanglian Xiexintang on Oxidative Stress Injury of Liver in Type 2 Diabetes Mellitus Rats Based on Nrf2/HO-1 Axis

Exploring Detoxication Mechanism of Dioscoreae Bulbiferae Rhizoma Processed with Phaseoli Radiati Semen Juice Based on Target Organ Ferroptosis

Related Author

HU Yan-wu

YU Jun-lin

ZHAO Jinghan

ZHU Zhengwang

WANG Linlin

ZHU Pingsheng

MIAO Mingsan

FU Xiaotong

Related Institution

Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-yao

School of Pharmacy， Henan University of Chinese Medicine

The First Clinical Medical College of Henan University of Chinese Medicine

Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences

Ningxia Medical University

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰